FDA Drug Application (021894) for XENAZINE by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number021894
Product Number001
FormTABLET;ORAL
Dosage12.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameXENAZINE
Active IngredientTETRABENAZINE



Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.